tiprankstipranks
Trending News
More News >
Croda International (GB:CRDA)
:CRDA

Croda International (CRDA) AI Stock Analysis

Compare
118 Followers

Top Page

GB

Croda International

(LSE:CRDA)

67Neutral
Croda International's stock score reflects a company with solid financial stability and positive corporate developments. However, the declining revenue, pressure on profit margins, and mixed technical indicators present challenges. The valuation appears fair and provides some support, but investors should remain cautious due to the bearish technical trend and operational challenges.

Croda International (CRDA) vs. S&P 500 (SPY)

Croda International Business Overview & Revenue Model

Company DescriptionCroda International (CRDA) is a global specialty chemical company headquartered in the United Kingdom. The company operates in various sectors, including personal care, life sciences, performance technologies, and industrial chemicals. Croda is renowned for its innovation in creating high-performance ingredients and technologies that serve diverse markets such as cosmetics, pharmaceuticals, and crop care. The company focuses on sustainable and bio-based solutions, leveraging its expertise in chemistry and technology to meet the evolving needs of its clients worldwide.
How the Company Makes MoneyCroda International generates revenue primarily through the sale of specialty chemicals and ingredients across its core sectors. The company's business model is centered around developing innovative, high-value products that address specific customer needs, particularly in the personal care and life sciences industries. Key revenue streams include the sale of ingredients for skincare, haircare, and pharmaceuticals, as well as performance additives for industrial applications. Croda invests significantly in research and development to drive innovation and maintain a competitive edge. Additionally, the company forms strategic partnerships and collaborations to enhance its offerings and expand its market reach. Sustainable practices and bio-based product lines also play a crucial role in attracting environmentally-conscious clients and contributing to Croda's financial performance.

Croda International Financial Statement Overview

Summary
Income Statement
Balance Sheet
Cash Flow
Breakdown
Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019
Income StatementTotal Revenue
1.69B2.09B1.89B1.39B1.38B
Gross Profit
730.00M864.90M825.60M550.30M445.80M
EBIT
247.50M477.80M437.00M308.30M335.90M
EBITDA
388.50M924.80M549.40M369.60M402.30M
Net Income Common Stockholders
171.00M649.30M320.80M201.60M223.90M
Balance SheetCash, Cash Equivalents and Short-Term Investments
172.50M320.60M112.80M106.50M81.90M
Total Assets
3.58B3.61B3.29B3.03B1.89B
Total Debt
710.10M615.80M936.00M907.00M629.60M
Net Debt
537.60M295.20M823.20M800.50M547.70M
Total Liabilities
1.21B1.18B1.53B1.43B1.02B
Stockholders Equity
2.35B2.42B1.75B1.59B861.60M
Cash FlowFree Cash Flow
156.80M160.90M190.50M166.30M193.80M
Operating Cash Flow
337.50M313.30M349.20M287.50M304.80M
Investing Cash Flow
-409.80M418.10M-218.40M-992.40M-112.90M
Financing Cash Flow
-52.40M-550.90M-111.90M722.40M-164.60M

Croda International Technical Analysis

Technical Analysis Sentiment
Neutral
Last Price2951.00
Price Trends
50DMA
2934.73
Positive
100DMA
3077.04
Negative
200DMA
3418.87
Negative
Market Momentum
MACD
19.03
Negative
RSI
58.21
Neutral
STOCH
85.81
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For GB:CRDA, the sentiment is Neutral. The current price of 2951 is above the 20-day moving average (MA) of 2769.75, above the 50-day MA of 2934.73, and below the 200-day MA of 3418.87, indicating a neutral trend. The MACD of 19.03 indicates Negative momentum. The RSI at 58.21 is Neutral, neither overbought nor oversold. The STOCH value of 85.81 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for GB:CRDA.

Croda International Peers Comparison

Overall Rating
UnderperformOutperform
Sector (49)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
GBHIK
72
Outperform
£4.27B15.2615.79%3.16%5.83%83.35%
67
Neutral
£4.12B25.996.84%3.62%-3.92%-7.30%
GBVCT
63
Neutral
£722.77M42.013.58%7.17%-5.21%-72.13%
GBSHI
54
Neutral
£161.40M-23.81%-5.41%-11.73%
GBPZC
53
Neutral
£325.94M-2.48%4.57%-16.16%80.50%
49
Neutral
$1.95B-1.49-20.76%3.74%1.00%-28.87%
45
Neutral
£140.50M-6.25%0.81%15.63%
* Basic Materials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
GB:CRDA
Croda International
2,951.00
-1,559.06
-34.57%
GB:SYNT
Synthomer
82.30
-181.20
-68.77%
GB:VCT
Victrex
831.00
-369.07
-30.75%
GB:PZC
PZ Cussons
77.70
-21.75
-21.87%
GB:SHI
SIG plc
15.56
-10.69
-40.72%
GB:HIK
Hikma Pharmaceuticals
1,985.00
116.79
6.25%

Croda International Earnings Call Summary

Earnings Call Date:Feb 25, 2025
(Q4-2024)
|
% Change Since: -5.62%|
Next Earnings Date:Jul 29, 2025
Earnings Call Sentiment Neutral
The earnings call presented a mixed picture with strong performance in Consumer Care and cash flow, but notable challenges in sales decline, particularly in Life Sciences and Industrial Specialties. Operational efficiencies are expected to improve future results, but the current performance is below expectations.
Q4-2024 Updates
Positive Updates
Consumer Care Growth
Sales in Consumer Care grew by 7% in constant currency, with a significant 11% increase in sales volumes. The division benefited from strong performance in F&F, which grew by 18%.
Strong Cash Flow
Free cash flow increased by over 9% to £181 million, supported by working capital discipline and reduced capital expenditure.
Operational Efficiency
Proactive cost actions and operational efficiencies are expected to deliver £40 million in savings against a 2024 baseline, with £25 million in savings targeted for 2025.
Positive Start to 2025
2025 has begun well, with expectations for good revenue growth in Consumer Care and Life Sciences, and operational efficiencies anticipated to offset inflation and incremental costs.
Negative Updates
Sales Decline
Group sales declined by 4% on a reported basis or by 1% at constant currency, with significant impacts from the absence of COVID-19 lipid sales.
Life Sciences Challenges
Sales in Life Sciences declined by 16% or 6% when adjusting for currency translation and prior year COVID-19 lipid sales, with particular challenges in consumer health and veterinary markets in Europe.
Operating Margin Decline
The adjusted operating margin decreased from 18.9% in 2023 to 17.2% in 2024, affected by the absence of COVID-19 lipid sales and bounce-back costs.
Industrial Specialties Struggles
Sales in Industrial Specialties were down by 1% on a reported basis, and while direct sales controlled by Croda grew, the overall segment faced challenges.
Company Guidance
During the call, Croda reported a mixed fiscal performance for 2024, with group sales down 1% or up 2% excluding prior year's £48 million covered lipid sales. The adjusted operating margin declined from 18.9% in 2023 to 17.2% in 2024, mainly due to the absence of high-margin COVID lipids, but showed improvement in the second half to 17.7%. Profit before tax was within guidance at £273 million, with a strong cash flow of £181 million, up 9%, and a modest dividend increase to 110p per share. Consumer Care sales grew 7%, while Industrial Specialties saw a 2% rise, and Life Sciences sales declined 6% but rebounded in the second half. Croda's 2025 outlook anticipates sales growth in Consumer Care and Life Sciences, with Industrial Specialties remaining flat, aiming for a profit before tax of £265 million to £295 million. They plan to enhance margins by increasing utilization and operational efficiencies, targeting £40 million in cost savings by 2026.

Croda International Corporate Events

Shareholder MeetingsDividendsBusiness Operations and StrategyFinancial Disclosures
Croda International’s 100th AGM: All Resolutions Passed
Positive
Apr 24, 2025

Croda International Plc held its 100th Annual General Meeting, where all proposed resolutions were passed by shareholder vote. Key decisions included the approval of financial statements, director elections, and a final dividend declaration. The meeting also authorized directors to allot securities and make market purchases of shares, reflecting a strategic focus on financial flexibility and shareholder value enhancement.

Spark’s Take on GB:CRDA Stock

According to Spark, TipRanks’ AI Analyst, GB:CRDA is a Neutral.

Croda International’s overall stock score reflects a balanced view of its strengths and challenges. The company shows solid financial stability and strategic corporate actions. However, declining sales and operating margins present significant challenges. While technical indicators suggest caution, the company’s valuation and positive corporate events provide some support. Investors should be mindful of the current challenges in revenue and profitability, as well as the bearish technical trend, when considering this stock.

To see Spark’s full report on GB:CRDA stock, click here.

Business Operations and StrategyFinancial Disclosures
Croda International Reports Strong Q1 2025 Sales Growth
Positive
Apr 23, 2025

Croda International reported an 8% increase in group sales for the first quarter of 2025, reaching £442 million, with growth across all sectors. The company is making progress on its five-point plan to boost sales and recover margins, despite geopolitical uncertainties, and maintains its full-year profit outlook.

Spark’s Take on GB:CRDA Stock

According to Spark, TipRanks’ AI Analyst, GB:CRDA is a Neutral.

Croda International’s overall stock score reflects a balanced view of its strengths and challenges. The company shows solid financial stability and strategic corporate actions. However, the declining sales and operating margins present significant challenges. While technical indicators suggest caution, the company’s valuation and positive corporate events provide some support. Investors should be mindful of the current challenges in revenue and profitability, as well as the bearish technical trend, when considering this stock.

To see Spark’s full report on GB:CRDA stock, click here.

Business Operations and Strategy
Croda International Announces Share Transactions Under Incentive Plan
Positive
Apr 11, 2025

Croda International Plc announced a series of share transactions involving key managerial personnel as part of the company’s Share Incentive Plan. The transactions, conducted on April 10, 2025, involved the purchase and matching of shares for executives and committee members, reflecting the company’s ongoing commitment to aligning management interests with shareholder value. This move is expected to strengthen stakeholder confidence and enhance the company’s market positioning by demonstrating a robust internal investment in its own growth and sustainability strategies.

Spark’s Take on GB:CRDA Stock

According to Spark, TipRanks’ AI Analyst, GB:CRDA is a Neutral.

Croda International’s overall stock score reflects solid financial stability and strategic corporate actions, offset by declining sales and operating margins. While technical indicators suggest caution, the company’s valuation and positive corporate events provide some support. Investors should be mindful of the current challenges in revenue and profitability, as well as the bearish technical trend, when considering this stock.

To see Spark’s full report on GB:CRDA stock, click here.

Business Operations and Strategy
Croda International’s Director Acquires Shares in Strategic Move
Neutral
Apr 11, 2025

Croda International Plc announced a transaction involving Danuta Gray, a Non-Executive Director, who purchased 550 ordinary shares at a price of £25.72627 each, totaling £14,149.45. This transaction, conducted on April 11, 2025, on the XLON exchange, signifies a strategic move by a key company figure, potentially impacting stakeholder confidence and market perception.

Spark’s Take on GB:CRDA Stock

According to Spark, TipRanks’ AI Analyst, GB:CRDA is a Neutral.

Croda International’s overall stock score reflects solid financial stability and strategic corporate actions, offset by declining sales and operating margins. While technical indicators suggest caution, the company’s valuation and positive corporate events provide some support. Investors should be mindful of the current challenges in revenue and profitability, as well as the bearish technical trend, when considering this stock.

To see Spark’s full report on GB:CRDA stock, click here.

Other
Croda International Announces Managerial Share Transactions
Neutral
Apr 7, 2025

Croda International Plc has announced a notification regarding transactions by persons discharging managerial responsibilities and their closely associated persons. The transactions involved the sale and purchase of ordinary shares by Thomas Michael Brophy, the Company Secretary, and Sarah Elizabeth Brophy. These transactions, conducted on April 7, 2025, at the London Stock Exchange (XLON), involved multiple trades at prices around £26.43 per share, reflecting ongoing financial activities by key personnel within the company.

Executive/Board ChangesBusiness Operations and Strategy
Croda International Grants Conditional Awards to New Executives
Neutral
Apr 4, 2025

Croda International Plc announced the granting of conditional awards under its Buy-Out Share Plan 2025 to Stephen Oxley and Thomas Riermeier, reflecting compensation for awards forfeited at their previous employers. This strategic move is part of their recruitment packages and involves the acquisition of ordinary shares, with vesting dates extending to 2029. The awards are performance-based, indicating Croda’s commitment to aligning executive incentives with company performance, potentially impacting its operational strategy and stakeholder interests.

Executive/Board ChangesBusiness Operations and Strategy
Croda International Aligns Executive Incentives with Shareholder Interests
Positive
Apr 3, 2025

Croda International Plc announced a grant of a Conditional Award under its Performance Share Plan 2014 to key executives, including the Chief Financial Officer and a Member of the Executive Committee. This move signifies the company’s commitment to aligning management incentives with shareholder interests, potentially impacting its operational focus and stakeholder relations positively.

Other
Croda International Director Purchases Shares, Signaling Confidence
Positive
Mar 31, 2025

Croda International Plc announced a transaction involving Mrs. Jacqueline Patricia Christine Ferguson, a Non-Executive Director, who purchased 155 ordinary shares at a price of £28.816245 each, totaling £4,466.52. This transaction reflects active involvement by the company’s leadership in its financial activities, potentially signaling confidence in the company’s market position and future performance.

Executive/Board ChangesBusiness Operations and Strategy
Croda CEO Steve Foots to Join Tate & Lyle Board
Positive
Mar 27, 2025

Croda International Plc has announced that its Group Chief Executive, Steve Foots, will join the Board of Tate & Lyle PLC as a Non-Executive Director starting 24 July 2025. This move could enhance Croda’s strategic positioning by fostering closer ties with Tate & Lyle, potentially benefiting stakeholders through increased collaboration opportunities in the chemicals and food ingredients sectors.

Executive/Board ChangesBusiness Operations and Strategy
Croda International Grants Conditional Awards to Key Executives
Positive
Mar 25, 2025

Croda International Plc announced the grant of Conditional Awards under its Performance Share Plan 2014 and Deferred Bonus Share Plan to several key executives. This move reflects the company’s commitment to aligning management incentives with shareholder interests and could potentially enhance the company’s operational performance and market positioning.

Business Operations and Strategy
Croda International CEO Executes Share Transactions
Neutral
Mar 25, 2025

Croda International Plc announced a series of transactions involving its Chief Executive, Stephen Edward Foots, who exercised conditional awards under the company’s Performance Share Plan and Deferred Bonus Share Plan. These transactions included the sale of shares to cover tax liabilities, reflecting a strategic financial maneuver by the executive. The transactions are part of routine financial management and are not expected to significantly impact the company’s market position or operations.

Executive/Board Changes
Croda International Announces Executive Share Transactions
Neutral
Mar 25, 2025

Croda International Plc announced a series of transactions involving Sandra Elaine Breene, a member of the Executive Committee. The transactions include the exercise of conditional awards under the company’s Performance Share Plan and Deferred Bonus Share Plan, as well as the sale of shares to cover tax liabilities. These transactions reflect the company’s ongoing commitment to aligning executive compensation with performance and shareholder interests.

Executive/Board ChangesBusiness Operations and Strategy
Croda International’s Executive Share Transactions Reflect Strategic Financial Management
Neutral
Mar 25, 2025

Croda International Plc announced a series of transactions involving its Company Secretary, Thomas Michael Brophy, who exercised conditional awards under the company’s Performance Share Plan and Deferred Bonus Share Plan. The transactions included the sale of shares to cover tax liabilities, reflecting routine financial management practices within the company. These actions are part of Croda’s ongoing efforts to align executive compensation with performance and shareholder interests.

Executive/Board ChangesBusiness Operations and Strategy
Croda International Executive Conducts Share Transaction
Neutral
Mar 25, 2025

Croda International Plc announced a transaction involving David Timothy Cherry, a member of the Executive Committee, who exercised a conditional award under the company’s Performance Share Plan and sold shares to cover tax liabilities. This transaction highlights the company’s ongoing commitment to its executive compensation strategy and may impact stakeholder perceptions of its governance practices.

Executive/Board ChangesBusiness Operations and Strategy
Croda International Executive Committee Member Executes Share Transactions
Neutral
Mar 25, 2025

Croda International Plc announced a transaction involving Anthony Damien Fitzpatrick, a member of its Executive Committee. The transaction included the exercise of conditional awards under the company’s Performance Share Plan and Deferred Bonus Share Plan, followed by the sale of shares to cover tax liabilities. This transaction reflects the company’s ongoing management of executive compensation and shareholding strategies.

Executive/Board Changes
Croda International Executive Exercises Share Awards
Neutral
Mar 25, 2025

Croda International Plc announced the exercise of conditional awards under its Performance Share Plan and Deferred Bonus Share Plan by Mark William Robinson, a member of the Executive Committee. The transactions involved the sale of shares to cover tax liabilities, reflecting the company’s ongoing management of executive compensation and incentives, which may influence investor perceptions and stakeholder interests.

Business Operations and StrategyFinancial Disclosures
Croda International Announces Managerial Share Transaction
Neutral
Mar 25, 2025

Croda International Plc announced a transaction involving Ritesh Tanna, a member of its Finance Committee, who exercised a conditional award under the company’s Performance Share Plan and subsequently sold shares to cover tax liabilities. This transaction highlights the company’s ongoing commitment to transparent financial practices and may impact investor perceptions and stakeholder confidence.

Shareholder MeetingsFinancial DisclosuresRegulatory Filings and Compliance
Croda International Releases 2024 Annual Report and Announces AGM
Neutral
Mar 13, 2025

Croda International Plc has released its 2024 Annual Report and announced the upcoming Annual General Meeting (AGM) scheduled for April 23, 2025. The company has made its Annual Report, Notice of AGM, and Sustainability Impact Report available to shareholders, reflecting its commitment to transparency and sustainability. This announcement underlines Croda’s ongoing efforts to engage with stakeholders and maintain compliance with regulatory requirements, potentially strengthening its market position.

Business Operations and Strategy
Croda International Aligns Management Interests with Shareholders Through Share Incentive Plan
Positive
Mar 11, 2025

Croda International Plc announced the purchase of shares under the Company’s Share Incentive Plan by the SIP Trustee, MUFG Corporate Markets Trustees (Nominees) Ltd. This transaction involves partnership shares purchased on behalf of persons discharging managerial responsibilities (PDMRs) and matching shares awarded to them. The transaction reflects Croda’s ongoing commitment to aligning the interests of its management with those of its shareholders, potentially enhancing stakeholder confidence and supporting the company’s strategic objectives.

Executive/Board Changes
Ian Bull to Chair Domino’s Pizza Group
Neutral
Mar 11, 2025

Croda International Plc has announced that Ian Bull, currently a Non-Executive Director and Audit Committee Chair of Dunelm Group plc, will assume the role of Chair at Domino’s Pizza Group Plc starting 24 April 2025. This move highlights a significant leadership transition within the company, potentially impacting its strategic direction and stakeholder relationships.

Regulatory Filings and Compliance
Croda International Announces Change in Major Shareholder Voting Rights
Neutral
Mar 10, 2025

Croda International Plc has announced a change in the voting rights held by Massachusetts Financial Services Company, which now holds 5.27% of the voting rights in Croda, up from a previous 4.99%. This change reflects an acquisition or disposal of voting rights and is significant for stakeholders as it indicates a shift in the ownership structure, potentially impacting company decisions and strategic directions.

Executive/Board Changes
Croda International Announces Board Member Retirement
Neutral
Mar 3, 2025

Croda International Plc announced the retirement of Julie Kim from its Board, effective 26 July 2025, after four years of service as a non-executive director. Julie Kim will be stepping down to concentrate on her new role as CEO of Takeda Pharmaceutical. This change reflects a strategic transition for Kim, while Croda acknowledges her valuable contributions and wishes her success in her future endeavors.

Other
Croda International Director Purchases Shares, Signaling Confidence
Positive
Feb 25, 2025

Croda International Plc announced a transaction involving the purchase of 400 ordinary shares by Ian Alan Bull, a Non-Executive Director of the company. The transaction, valued at £12,960.72, took place on February 25, 2025, at the London Stock Exchange (XLON). This purchase reflects confidence in the company’s future prospects and may influence stakeholder perceptions positively.

DividendsBusiness Operations and StrategyFinancial Disclosures
Croda International Navigates Transitional Year with Strategic Focus on Growth
Neutral
Feb 25, 2025

Croda International reported a challenging yet transitional year for 2024, with sales slightly declining by 1% at constant currency, excluding Covid-19 lipid sales. Despite a decrease in operating profit and margin, the company showed resilience with strong cash flow and a slight increase in dividends. The Consumer Care segment showed robust growth driven by local and regional customers, while Life Sciences faced challenges due to the absence of Covid-19 lipid sales. Croda is focusing on innovation and cost efficiencies to drive future earnings growth, expecting improved sales in Consumer Care and Life Sciences in 2025.

Business Operations and Strategy
Croda International Announces Managerial Share Purchases
Positive
Feb 11, 2025

Croda International has announced the purchase of shares under the Company’s Share Incentive Plan by the SIP Trustee, benefiting key managerial personnel. This move involves the acquisition of partnership and matching shares, signaling a strategic approach to align managerial interests with company performance, potentially impacting stakeholder confidence and market positioning positively.

Glossary
OutperformA stock rated as "Outperform" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests that the stock is likely to deliver higher returns compared to the average returns of other stocks in the same sector or market index. Investors might consider this stock a good buying opportunity.
NeutralA stock rated as "Neutral" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly attractive nor unattractive for investment. Investors may consider holding onto the stock, as it is not expected to either significantly outperform or underperform the market.
UnderperformA stock rated as "Underperform" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests that the stock may deliver lower returns compared to the average returns of other stocks in the same sector or market index. Investors might consider selling the stock or avoiding it as an investment.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.